Onconetix (ONCO) Gross Profit (2024 - 2026)
Onconetix (ONCO) posted quarterly Gross Profit of -$1655.0 for Q1 2026, down 103.61% year-over-year from $45832.0 in Q1 2025, and down 100.67% quarter-over-quarter from $247684.0 in Q4 2025.
Onconetix (ONCO) Gross Profit (2024 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Gross Profit for 3 consecutive years, with -$1655.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit fell 103.61% year-over-year to -$1655.0; the TTM figure through Mar 2026 stood at $585426.0 (down 35.8% YoY), while the FY2025 annual figure was $632913.0, down 40.01% from the prior year.
- Gross Profit declined to -$1655.0 in Q1 2026 per ONCO's latest filing, from $247684.0 in the prior quarter.
- Across five years, Gross Profit topped out at $659968.0 in Q4 2024 and bottomed at -$1655.0 in Q1 2026.
- Historically, Gross Profit has averaged $187372.9 across 3 years, with a median of $105414.0 in 2024.
- Annual changes were most pronounced in 2025 — Gross Profit surged 155.08% — and 2026, when it slumped 103.61%.
- Onconetix's Gross Profit stood at $659968.0 in 2024, then plunged by 62.47% to $247684.0 in 2025, then plunged by 100.67% to -$1655.0 in 2026.
- Business Quant data shows ONCO's Gross Profit at -$1655.0 in Q1 2026, $247684.0 in Q4 2025, and $268894.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,303.00 |
| Jun 30, 2026 | 4,303.00 |
| Mar 31, 2026 | -1,655.00 |
| Mar 31, 2026 | -1,655.00 |
| Dec 31, 2025 | 247,684.00 |
| Dec 31, 2025 | 247,684.00 |
| Sep 30, 2025 | 268,894.00 |
| Sep 30, 2025 | 268,894.00 |
| Jun 30, 2025 | 70,503.00 |
| Jun 30, 2025 | 70,503.00 |
| Mar 31, 2025 | 45,832.00 |
| Mar 31, 2025 | 45,832.00 |
| Dec 31, 2024 | 659,968.00 |
| Dec 31, 2024 | 659,968.00 |
| Sep 30, 2024 | 105,414.00 |
| Sep 30, 2024 | 105,414.00 |
| Jun 30, 2024 | 100,716.00 |
| Jun 30, 2024 | 100,716.00 |
| Mar 31, 2024 | 189,000.00 |
| Mar 31, 2024 | 189,000.00 |